Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

Abstract Background Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolution, epidemiological data regarding the overlap among them. We aimed to...

Full description

Bibliographic Details
Main Authors:	Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Johan Bodegård, Lawrence A. Leiter, Subodh Verma, Hiddo J. Lambers Heerspink, Avraham Karasik, Ofri Mosenzon
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Series:	Cardiovascular Diabetology
Subjects:	Type-2 Diabetes Heart Failure Chronic Kidney Disease Cross-sectional Study Epidemiology Diabetes-cardio-renal Spectrum
Online Access:	https://doi.org/10.1186/s12933-022-01521-9

Similar Items

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
by: Meir Schechter, et al.
Published: (2021-08-01)

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
by: Meir Schechter, et al.
Published: (2023-05-01)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers
by: Sok Cin Tye, et al.
Published: (2022-04-01)

Nepal Pioneer Worksite Intervention Study to lower cardio-metabolic risk factors: design and protocol
by: Archana Shrestha, et al.
Published: (2019-02-01)

Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes
by: Dabei Fan, et al.
Published: (2018-05-01)

Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01)

Cardio-Oncology – A new subspecialty with collaboration at its heart
by: Arjun K. Ghosh, et al.
Published: (2017-07-01)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
by: Daniel H. Van Raalte, et al.
Published: (2022-05-01)

Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
by: Zehua Liang, et al.
Published: (2022-09-01)

Cardio-Oncology: Success Breeds New Challenges, Opportunities
by: Charles A. Bomzer, et al.
Published: (2014-08-01)

Cardio-Oncology in Iran: Cardio-toxicity Registry
by: Azin Alizadehasl, et al.
Published: (2022-08-01)

A Call to Action to Address the Burden of Cardiovascular Disease in People with Diabetes
by: Karolay Lorenty, et al.
Published: (2022-12-01)

Cardio-Metabolic and Mental Health Outcomes Before and During the COVID-19 Pandemic in a Cohort of Women With Gestational Diabetes Mellitus in Switzerland
by: Dan Yedu Quansah, et al.
Published: (2022-07-01)

Correlation of elderly nutritional status with cardio-vascular disease and diabetes
by: Dorosty A R, et al.
Published: (2007-07-01)

The Effect of 8 Weeks of Cardio Kickboxing Training on Some Metabolic and Inflammatory Indicators in Adults with Type 2 Diabetes
by: Seyed Morteza Tayebi, et al.
Published: (2023-12-01)

Prospective study: Aldehyde dehydrogenase 2 gene is associated with cardio‐cerebrovascular complications in type 2 diabetes patients
by: Qingfang He, et al.
Published: (2021-10-01)

Encouraging Tactics with Genetically Modified Probiotics to Improve Immunity for the Prevention of Immune-Related Diseases including Cardio-Metabolic Disorders
by: Tomoko Asai, et al.
Published: (2022-12-01)

Cardio-Oncology Educational Program: National Survey as the First Step to Start
by: Sergey Kozhukhov, et al.
Published: (2021-08-01)

Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening
by: Rebeca Lorca, et al.
Published: (2023-12-01)

Complicações pós-operatórias das cirurgias cárdio-pulmonares e tratamento fisioterápico
by: Maria Tereza Aguiar Pessoa Morano, et al.
Published: (2012-01-01)

The Establishment of the Nordic Cardio-Oncology Society
by: Agneta Månsson Broberg, MD, PhD, et al.
Published: (2020-06-01)

Physical activity cardio-surgical patients
by: Joanna Stocka, et al.
Published: (2017-01-01)

Cardio-oncology: need for novel structures
by: Lars Michel, et al.
Published: (2019-01-01)

An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020
by: Anecita P. Fadol, et al.
Published: (2020-09-01)

Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology
by: Samaneh Zandifar, et al.
Published: (2024-01-01)

Comparison of Patients’ Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs
by: Pamela Piña, et al.
Published: (2022-09-01)

Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01)

Cardio‐Oncology at the Beginning of a New Decade
by: Isabella M. Grumbach
Published: (2020-01-01)

Reanimación cardio-pulmonar-cerebral: una prioridad que no debe esperar
by: Ramón García Hernández
Published: (2014-04-01)

Reanimación cardio-pulmonar-cerebral: una prioridad que no debe esperar
by: Ramón García Hernández
Published: (2014-04-01)

Reanimación cardio-pulmonar-cerebral: una prioridad que no debe esperar
by: Ramón García Hernández
Published: (2014-04-01)

A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial
by: Mahen Wijesuriya, et al.
Published: (2017-08-01)

Editorial: Cardio-oncology: mechanisms and therapeutics
by: Yan Ma, et al.
Published: (2023-05-01)

The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.
by: Bauke Schievink, et al.
Published: (2014-01-01)

Sore, Hot, and at Risk: The Emerging Specialty of Cardio‐Rheumatology
by: Brittany Weber, et al.
Published: (2023-06-01)

Cardio-oncology and COVID 19: Lessons learned, past reflections and future deliberations
by: Sherry-Ann Brown
Published: (2022-05-01)

The effect of using the minimized cardio-pulmonary bypass Systems for Coronary Artery Bypass Grafting in diabetic patients
by: Turki B. Albacker, et al.
Published: (2021-06-01)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
by: Dong-Woo Kang, et al.
Published: (2022-01-01)

Birth and Maturation of Cardio-Oncology
by: Deepak L. Bhatt, MD, MPH
Published: (2019-09-01)

Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons – results of further analyses of DIABRISK-SL in those below 18 years of age
by: Nikolaos Fountoulakis, et al.
Published: (2019-09-01)